Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

International Stem Cell Corporation ISCO

Set alert

Price alert · ISCO

All alert types
0.15 USD 0.00 +3.57%

At close · Oct 30

0.145 Day range 0.145
0.12 52-week range 0.54
YTD
+3.57%
1 year
-3.33%
Open
0.145
Prev close
0.14
Mkt cap
1.16M
Vol
4
Avg vol
32.95K
EPS
-0.08
P/E
0.00
More statistics
Low
0.145
High
0.145

3M chart

Chart tools
Interval
1m5m15m30m

Signals (10)
NameDateAgo
MACD: Sell SignalOct 21, 20261 week ago
RSI: OversoldOct 21, 20261 week ago
MACD: Buy SignalOct 19, 20262 weeks ago
SMA: BearishSep 28, 20261 month ago
SMA: BullishSep 24, 20261 month ago
SMA: BearishSep 21, 20261 month ago
SMA: BearishSep 8, 20261 month ago
MACD: Sell SignalAug 28, 20262 months ago
RSI: OverboughtAug 19, 20262 months ago
RSI: OverboughtAug 11, 20262 months ago

Financial health

Altman Z-Score

-29.29 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -2.8×
FY 2016: -3.0×FY 2017: -1.1×FY 2018: -4.6×FY 2019: -1.0×FY 2020: -1.0×FY 2021: -3.6×FY 2022: -3.1×FY 2023: -3.8×FY 2024: -3.1×FY 2025: -2.8×
FY 2016 5y median -3.1× FY 2025
P/S 0.1×
FY 2016: 0.5×FY 2017: 0.9×FY 2018: 0.9×FY 2019: 0.5×FY 2020: 0.4×FY 2021: 0.5×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
P/B -0.3×
FY 2016: 0.9×FY 2017: 3.2×FY 2018: 3.9×FY 2019: -1.5×FY 2020: -0.6×FY 2021: -0.8×FY 2022: -0.3×FY 2023: -0.1×FY 2024: -0.2×FY 2025: -0.3×
FY 2016 5y median -0.3× FY 2025
P/FCF -32.0×
FY 2016: -0.6×FY 2017: -2.2×FY 2018: -5.6×FY 2019: -2.3×FY 2020: -6.2×FY 2021: -2.7×FY 2022: 4.5×FY 2023: 0.6×FY 2024: -4.3×FY 2025: -32.0×
FY 2016 5y median -2.7× FY 2025
EV/EBITDA -80.4×
FY 2016: 17.0×FY 2017: -1.1×FY 2018: -6.1×FY 2019: -1.9×FY 2020: -2.7×FY 2021: -14.9×FY 2022: 226×FY 2023: 15.3×FY 2024: 23.0×FY 2025: -80.4×
FY 2016 5y median 15.3× FY 2025
EV/Sales 0.4×
FY 2016: 0.4×FY 2017: 0.9×FY 2018: 1.0×FY 2019: 0.8×FY 2020: 0.9×FY 2021: 1.1×FY 2022: 0.6×FY 2023: 0.4×FY 2024: 0.4×FY 2025: 0.4×
FY 2016 5y median 0.4× FY 2025
FCF Yield -3.1%
FY 2016: -157.3%FY 2017: -45.2%FY 2018: -17.8%FY 2019: -43.4%FY 2020: -16.1%FY 2021: -36.5%FY 2022: 22.3%FY 2023: 170.5%FY 2024: -23.5%FY 2025: -3.1%
FY 2016 5y median -3.1% FY 2025

Profitability

Gross Margin 55.7%
FY 2016: 72.9%FY 2017: 71.5%FY 2018: 63.3%FY 2019: 58.5%FY 2020: 61.0%FY 2021: 59.1%FY 2022: 60.0%FY 2023: 59.2%FY 2024: 58.6%FY 2025: 55.7%
FY 2016 5y median 59.1% FY 2025
Operating Margin -2.9%
FY 2016: -67.7%FY 2017: -66.3%FY 2018: -31.3%FY 2019: -60.5%FY 2020: -39.5%FY 2021: -26.8%FY 2022: -2.4%FY 2023: -8.5%FY 2024: -0.7%FY 2025: -2.9%
FY 2016 5y median -2.9% FY 2025
Net Margin -4.6%
FY 2016: -15.1%FY 2017: -81.4%FY 2018: -19.2%FY 2019: -45.9%FY 2020: -39.8%FY 2021: -14.5%FY 2022: -5.7%FY 2023: -1.7%FY 2024: -2.3%FY 2025: -4.6%
FY 2016 5y median -4.6% FY 2025
ROE 10.3%
FY 2016: -31.3%FY 2017: -294.0%FY 2018: -84.0%FY 2019: 150.4%FY 2020: 65.5%FY 2021: 22.7%FY 2022: 10.3%FY 2023: 3.1%FY 2024: 5.3%FY 2025: 10.3%
FY 2016 5y median 10.3% FY 2025
ROIC -6.7%
FY 2016: -140.9%FY 2017: -239.4%FY 2018: -72.9%FY 2019: -112.9%FY 2020: -65.7%FY 2021: -50.8%FY 2022: -4.8%FY 2023: -15.5%FY 2024: -1.6%FY 2025: -6.7%
FY 2016 5y median -6.7% FY 2025
ROA -8.7%
FY 2016: -15.3%FY 2017: -88.4%FY 2018: -27.3%FY 2019: -65.6%FY 2020: -53.7%FY 2021: -21.0%FY 2022: -9.1%FY 2023: -2.4%FY 2024: -4.0%FY 2025: -8.7%
FY 2016 5y median -8.7% FY 2025

Growth (YoY)

Revenue 0.2%
FY 2016: -5.1%FY 2017: 4.1%FY 2018: 48.7%FY 2019: -14.6%FY 2020: -24.7%FY 2021: 0.7%FY 2022: 14.0%FY 2023: -4.8%FY 2024: 16.6%FY 2025: 0.2%
FY 2016 FY 2025
Operating Income -292.6%
FY 2016: -6.3%FY 2017: -1.9%FY 2018: 29.7%FY 2019: -64.9%FY 2020: 50.8%FY 2021: 31.8%FY 2022: 89.8%FY 2023: -238.3%FY 2024: 89.7%FY 2025: -292.6%
FY 2016 FY 2025
EPS (diluted) -91.6%
FY 2016: 73.6%FY 2017: -329.4%FY 2018: 77.4%FY 2019: -75.8%FY 2020: 34.5%FY 2021: 65.8%FY 2022: 55.2%FY 2023: 71.8%FY 2024: -59.1%FY 2025: -91.6%
FY 2016 FY 2025
Free Cash Flow 77.1%
FY 2016: -5.8%FY 2017: 41.5%FY 2018: 42.0%FY 2019: -8.5%FY 2020: 76.3%FY 2021: -198.9%FY 2022: 123.9%FY 2023: 163.6%FY 2024: -118.1%FY 2025: 77.1%
FY 2016 FY 2025

Financial Health

Current Ratio 0.7×
FY 2016: 0.7×FY 2017: 0.6×FY 2018: 0.7×FY 2019: 1.8×FY 2020: 1.5×FY 2021: 0.5×FY 2022: 0.6×FY 2023: 0.7×FY 2024: 0.8×FY 2025: 0.7×
FY 2016 5y median 0.7× FY 2025
Quick Ratio 0.4×
FY 2016: 0.3×FY 2017: 0.3×FY 2018: 0.4×FY 2019: 1.2×FY 2020: 0.9×FY 2021: 0.3×FY 2022: 0.3×FY 2023: 0.5×FY 2024: 0.5×FY 2025: 0.4×
FY 2016 5y median 0.4× FY 2025
Debt / Equity -0.9×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.8×FY 2019: -1.2×FY 2020: -1.0×FY 2021: -0.9×FY 2022: -0.9×FY 2023: -1.0×FY 2024: -1.0×FY 2025: -0.9×
FY 2016 5y median -0.9× FY 2025
Net Debt / EBITDA -57.1×
FY 2016: -0.6×FY 2017: 0.1×FY 2018: -0.5×FY 2019: -0.8×FY 2020: -1.5×FY 2021: -7.7×FY 2022: 161×FY 2023: 12.8×FY 2024: 18.4×FY 2025: -57.1×
FY 2016 5y median 12.8× FY 2025
Interest Coverage -1.8×
FY 2016: -809×FY 2017: -83.8×FY 2018: -72.4×FY 2019: -74.4×FY 2020: -24.9×FY 2021: -15.0×FY 2022: -1.5×FY 2023: -4.8×FY 2024: -0.5×FY 2025: -1.8×
FY 2016 5y median -1.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31